Evidence mapPaperPMID 41869040Full record

ReviewFrontiers in endocrinology2026

Diabetes associated pericyte metabolic signatures and pathogenesis of diabetic retinopathy.

Casandra Carrillo, Teri L Belecky-Adams, Nader Sheibani

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Casandra CarrilloDepartment of Biology, Indiana University Indianapolis, Indianapolis, IN, United States.
Teri L Belecky-AdamsDepartment of Biology, Indiana University Indianapolis, Indianapolis, IN, United States.
Nader SheibaniDepartment of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.

Funding

CORE--PATHOLOGY/IMAGINGP30EY016665 · UNIVERSITY OF WISCONSIN-MADISON · 2005 to 2025
$1.1M
NEI NIH HHS P30 EY016665
6 · The paper itself

Abstract

Pericytes are metabolically active perivascular supporting cells. They are essential for establishing and maintaining the inner blood retinal barrier and retinal neurovascular homeostasis. In diabetic retinopathy, the chronic hyperglycemic environment adversely affects pericyte functions including their glucose flux and metabolism. The early alterations in pericyte metabolic signatures during diabetes make them susceptible as an early damage target. Altered pericyte glucose flux through the polyol pathway, pentose phosphate pathway, hexosamine biosynthesis pathway, protein kinase C pathway, and advanced glycated end products pathway are responsible for mitochondrial dysfunction, inflammation, and oxidative stress. These metabolic changes in pericytes regulate vascular blood flow and tight junctions' integrity leading to vascular dysfunction and disease progression. This review aims to discuss the current understanding of pericyte metabolic signatures and altered glucose metabolism under hyperglycemic conditions like those present in diabetes. We also aim to highlight the need for further investigation of how pericyte metabolic activities, particularly among pericyte subtypes of the retina and other organs, are coordinated. This knowledge will help to further our understanding of how to preserve the blood tissue barrier and its function, and to prevent not only diabetic retinopathy but also vascular dysfunction in other organs impacted by diabetes.

Indexed as

Diabetes MellitusDiabetic RetinopathyPericytesAnimalsBlood-Retinal BarrierGlucoseHumansGlucosediabetesdiabetic retinopathymetabolismneurovascular unitpericytes

Identifiers

PMID41869040
PMCPMC13002368

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.